Media center

Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients

Owkin announces MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer

Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer

IA et santé: l’AP-HP renouvelle son accord avec Owkin pour accélérer l'innovation IA au service des patients

Owkin Collaborates with MSD to Assess the Impact of MSIntuit® CRC to Accelerate Patient Identification for Therapeutic Decisions

Owkin and Finnish Biobanks collaborate to advance medical research

Owkin’s MSIntuit CRC wins the Best Medical Technology Prix Galien Award

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 

Aster Insights and Owkin collaborate to accelerate research in breast cancer

Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin

Owkin expands collaboration with Sanofi to apply AI for drug positioning in immunology